• Something wrong with this record ?

Forkhead Domains of FOXO Transcription Factors Differ in both Overall Conformation and Dynamics

K. Psenakova, K. Kohoutova, V. Obsilova, MJ. Ausserlechner, V. Veverka, T. Obsil,

. 2019 ; 8 (9) : . [pub] 20190824

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc20023735

FOXO transcription factors regulate cellular homeostasis, longevity and response to stress. FOXO1 (also known as FKHR) is a key regulator of hepatic glucose production and lipid metabolism, and its specific inhibition may have beneficial effects on diabetic hyperglycemia by reducing hepatic glucose production. Moreover, all FOXO proteins are considered potential drug targets for drug resistance prevention in cancer therapy. However, the development of specific FOXO inhibitors requires a detailed understanding of structural differences between individual FOXO DNA-binding domains. The high-resolution structure of the DNA-binding domain of FOXO1 reported in this study and its comparison with structures of other FOXO proteins revealed differences in both their conformation and flexibility. These differences are encoded by variations in protein sequences and account for the distinct functions of FOXO proteins. In particular, the positions of the helices H1, H2 and H3, whose interface form the hydrophobic core of the Forkhead domain, and the interactions between hydrophobic residues located on the interface between the N-terminal segment, the H2-H3 loop, and the recognition helix H3 differ among apo FOXO1, FOXO3 and FOXO4 proteins. Therefore, the availability of apo structures of DNA-binding domains of all three major FOXO proteins will support the development of FOXO-type-specific inhibitors.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023735
003      
CZ-PrNML
005      
20230519101208.0
007      
ta
008      
201125s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cells8090966 $2 doi
035    __
$a (PubMed)31450545
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Psenakova, Katarina $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic. Department of Structural Biology of Signaling Proteins, Division BIOCEV, Institute of Physiology of the Czech Academy of Sciences, 252 50 Vestec, Czech Republic.
245    10
$a Forkhead Domains of FOXO Transcription Factors Differ in both Overall Conformation and Dynamics / $c K. Psenakova, K. Kohoutova, V. Obsilova, MJ. Ausserlechner, V. Veverka, T. Obsil,
520    9_
$a FOXO transcription factors regulate cellular homeostasis, longevity and response to stress. FOXO1 (also known as FKHR) is a key regulator of hepatic glucose production and lipid metabolism, and its specific inhibition may have beneficial effects on diabetic hyperglycemia by reducing hepatic glucose production. Moreover, all FOXO proteins are considered potential drug targets for drug resistance prevention in cancer therapy. However, the development of specific FOXO inhibitors requires a detailed understanding of structural differences between individual FOXO DNA-binding domains. The high-resolution structure of the DNA-binding domain of FOXO1 reported in this study and its comparison with structures of other FOXO proteins revealed differences in both their conformation and flexibility. These differences are encoded by variations in protein sequences and account for the distinct functions of FOXO proteins. In particular, the positions of the helices H1, H2 and H3, whose interface form the hydrophobic core of the Forkhead domain, and the interactions between hydrophobic residues located on the interface between the N-terminal segment, the H2-H3 loop, and the recognition helix H3 differ among apo FOXO1, FOXO3 and FOXO4 proteins. Therefore, the availability of apo structures of DNA-binding domains of all three major FOXO proteins will support the development of FOXO-type-specific inhibitors.
650    _2
$a zvířata $7 D000818
650    _2
$a forkhead box protein O1 $x chemie $x genetika $x metabolismus $7 D000071161
650    _2
$a protein FOXO3 $x chemie $x genetika $x metabolismus $7 D000071316
650    _2
$a forkhead transkripční faktory $x chemie $x genetika $x metabolismus $7 D051858
650    _2
$a lidé $7 D006801
650    _2
$a hydrofobní a hydrofilní interakce $7 D057927
650    _2
$a magnetická rezonanční spektroskopie $7 D009682
650    _2
$a myši $7 D051379
650    _2
$a molekulární modely $7 D008958
650    _2
$a proteinové domény $7 D000072417
650    _2
$a sekundární struktura proteinů $7 D017433
650    _2
$a sekvenční analýza proteinů $7 D020539
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kohoutova, Klara $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic.
700    1_
$a Obsilova, Veronika $u Department of Structural Biology of Signaling Proteins, Division BIOCEV, Institute of Physiology of the Czech Academy of Sciences, 252 50 Vestec, Czech Republic.
700    1_
$a Ausserlechner, Michael J $u Department of Pediatrics I, Medical University Innsbruck, A-6020 Innsbruck, Austria.
700    1_
$a Veverka, Václav, $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 166 10 Prague, Czech Republic. vaclav.veverka@uochb.cas.cz. Department of Cell Biology, Faculty of Science, Charles University, 128 43 Prague, Czech Republic. vaclav.veverka@uochb.cas.cz. $d 1973- $7 xx0301322
700    1_
$a Obsil, Tomas $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic. obsil@natur.cuni.cz. Department of Structural Biology of Signaling Proteins, Division BIOCEV, Institute of Physiology of the Czech Academy of Sciences, 252 50 Vestec, Czech Republic. obsil@natur.cuni.cz.
773    0_
$w MED00194911 $t Cells $x 2073-4409 $g Roč. 8, č. 9 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31450545 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20230519101201 $b ABA008
999    __
$a ok $b bmc $g 1596054 $s 1114411
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 8 $c 9 $e 20190824 $i 2073-4409 $m Cells $n Cells $x MED00194911
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Archiving options